ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesG62.0

G62.0

Billable

Drug-induced polyneuropathy

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 G62.0 is a billable code used to indicate a diagnosis of drug-induced polyneuropathy.

Key Diagnostic Point:

Drug-induced polyneuropathy is a condition characterized by damage to multiple peripheral nerves due to the toxic effects of certain medications. This condition can manifest as a variety of symptoms, including numbness, tingling, burning sensations, and weakness in the limbs. The polyneuropathy may be dose-dependent, meaning that higher doses of the offending drug can lead to more severe symptoms. Common drugs associated with this condition include chemotherapeutic agents, certain antibiotics, and antiretroviral medications. Diagnosis typically involves a thorough clinical history, including a review of medications, and may be supported by electrodiagnostic studies such as nerve conduction studies and electromyography (EMG). These studies help to assess the extent of nerve damage and differentiate drug-induced polyneuropathy from other types of neuropathies. Management focuses on discontinuing the offending agent and providing symptomatic relief, which may include pain management and physical therapy. In some cases, nerve regeneration may occur once the drug is withdrawn, but recovery can be variable.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variety of drugs that can cause polyneuropathy
  • Need for thorough documentation of medication history
  • Differentiation from other types of neuropathies
  • Potential for overlapping symptoms with other conditions

Audit Risk Factors

  • Inadequate documentation of drug history
  • Failure to link symptoms to specific medications
  • Misclassification of polyneuropathy type
  • Lack of supporting electrodiagnostic study results

Specialty Focus

Medical Specialties

Neurology

Documentation Requirements

Detailed history of symptoms, medication review, and results of electrodiagnostic studies.

Common Clinical Scenarios

Patients presenting with symptoms of neuropathy after starting new medications.

Billing Considerations

Ensure clear documentation of the timeline of medication use and symptom onset.

Oncology

Documentation Requirements

Documentation of chemotherapy regimens and any supportive medications.

Common Clinical Scenarios

Patients experiencing neuropathy following chemotherapy treatment.

Billing Considerations

Document the specific chemotherapeutic agents used and their dosages.

Coding Guidelines

Inclusion Criteria

Use G62.0 When
  • According to ICD
  • 10 guidelines, G62
  • 0 should be used when polyneuropathy is directly linked to drug exposure
  • Documentation must clearly indicate the relationship between the drug and the neuropathy
  • Electrodiagnostic studies should be documented to support the diagnosis

Exclusion Criteria

Do NOT use G62.0 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

95900CPT Code

Nerve conduction studies

Clinical Scenario

Used to evaluate the extent of nerve damage in suspected drug-induced polyneuropathy.

Documentation Requirements

Results of nerve conduction studies must be documented in the patient's record.

Specialty Considerations

Neurologists should ensure that the studies are performed and interpreted correctly.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced polyneuropathy, improving the ability to track and analyze cases related to medication exposure.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced polyneuropathy, improving the ability to track and analyze cases related to medication exposure.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of drug-induced polyneuropathy, improving the ability to track and analyze cases related to medication exposure.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What types of medications are commonly associated with drug-induced polyneuropathy?

Common medications include chemotherapeutic agents, certain antibiotics, and antiretroviral drugs. It's important to review the patient's medication history to identify potential culprits.